Mounjaro®
Starting from £179.99/mo
Start journey Learn moreInjecting Mounjaro is uncomfortable for some people and barely noticeable for others. Most describe the sensation as a brief, mild sting (a second or two at most) rather than real pain. The needle is very fine and short, and many people find the process far less daunting than they expected. Mounjaro is a prescription-only medicine, so a clinician assesses whether it is right for you before any pen is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks, and it deserves a proper answer, because the two causes need different solutions. The initial prick comes from the needle entering the skin. The KwikPen uses a fine gauge needle, similar to those used for insulin, so most people report nothing more than a brief flicker of sensation. That part is over in under a second.
The second kind of discomfort, a dull ache or mild burning that lingers for a minute or two after the injection, usually comes from the medicine being deposited in the tissue beneath the skin. Injecting too quickly, or into skin that is cold straight from the fridge, makes this more noticeable. Letting the pen sit at room temperature for 20 to 30 minutes before use makes a real difference for most people. The full injection technique guide covers this step by step.
Redness, a small lump or mild itching at the site afterwards are listed in the Mounjaro prescribing information as common injection-site reactions, and the NHS tirzepatide page confirms these are generally short-lived. They are worth mentioning to your prescriber if they persist beyond a day or two, but they are not usually a sign that anything has gone wrong.
Site choice matters more than most people expect. The abdomen, outer thigh and upper arm are all licensed injection sites for Mounjaro, and they genuinely feel different. The abdomen tends to be the easiest to reach and, for many people, the least sensitive. The thigh is a good alternative if the abdomen is tender. The upper arm is practical but harder to manage alone without a little practice.
Rotating between these sites with each weekly injection is not optional, it is part of good technique. Injecting repeatedly into the same small area allows scar tissue to build up, and that tissue absorbs the medicine less predictably and can become more sensitive over time. Details on how to vary sites safely are covered on our Mounjaro injection page.
Pinching up a fold of skin gently before injecting reduces the risk of hitting muscle rather than the fat layer beneath the skin. Muscle injections sting considerably more. If you are on a lower body-fat level or injecting the upper arm, this technique is particularly useful. Clean the skin first (alcohol swabs are a straightforward way to do this) and let it dry fully before the needle goes in, since residual alcohol on the skin can sting.
Mild soreness that fades within a few hours is normal and not a reason to worry. Soreness that lasts longer, or a hard lump that does not resolve within a week, is worth looking at more carefully. The most common causes are injecting too shallowly (into the skin rather than beneath it), not rotating sites, or reusing the same needle. Needles should be changed for every injection; a blunted tip is a meaningful contributor to discomfort.
Persistent site pain that is getting worse, spreading redness, warmth or any signs of infection are not things to manage alone. Contact your prescriber or your GP promptly. For context on what else can cause localised discomfort and how to distinguish it from normal post-injection sensitivity, the injection site soreness page goes into more detail.
If you are thinking about the broader picture of starting treatment (not just the injection itself) our Mounjaro overview covers how the medicine works, what the first weeks look like and what the clinical trial results showed.
For the vast majority of people who take Mounjaro, the weekly injection quickly becomes unremarkable, the kind of task that takes 30 seconds and stops registering as a big deal after a few weeks. That said, if you have a genuine needle phobia or significant anxiety about injections, that is worth raising directly with a prescriber before you start, not as an afterthought. It can affect which treatment approach makes most sense for you, and our guide on whether the Mounjaro injection hurts is a good place to read through what people typically experience before deciding.
There are now other formats to consider too. If the injection aspect is a real barrier, it is worth reading about the range of treatments available, including the oral option approved in the UK in 2026, to see whether a different route might suit you better. The cost picture across treatments varies, and the Mounjaro cost page sets out what private treatment typically involves. Whatever you decide, a prescriber at a GPhC-registered service like ours reviews your full picture before anything is prescribed, not a form, not an algorithm, a named clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.